PlainRecalls
FDA Drug Moderate Class II Terminated

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Reported: October 17, 2018 Initiated: October 2, 2018 #D-0011-2019

Product Description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Reason for Recall

Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.

Details

Units Affected
158,466 bottles
Distribution
Product was distributed Nationwide in the USA and Puerto Rico.
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 158,466 bottles.
Why was this product recalled?
Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 17, 2018. Severity: Moderate. Recall number: D-0011-2019.